AbbVie Inc (NYSE: ABBV)

• Support level
  $267.14
• Resistance level
  N/A

• Beta
  0.3
• RSI (14-day)
  72.6

• ABBV is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
• ABBV is one of this month's top performers with a return of 7.5 percent, beating 90 percent of stocks in the S&P-100.
• Volatility is forecast to fall over the next month.
• With RSI > 70, ABBV is overbought. Odds slightly favor a short-term price reversal.
• Price broke above prior resistance level - a short-term bullish signal.

Value at risk (VaR)

There is an estimated 5% probability that the stock price will fall by more than VaR in time period.

• In the next week
  5.6%
• In the next month
  13.4%
• In the next year
  49.8%